Browse studies

Find your next paid study

1 recruiting study matching your filters

A First-in-Human Phase I Study of ATG-031 in Patients With Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

ATG-031 study (alias: PERFORM) is a multicenter, open-label, Phase 1 study of ATG-031 in patients with advanced solid tumors or B-NHL. The study design include…

Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas

Antengene Biologics LimitedNCT06028373